# ArrowMark Partners: portfolio, investments and team > ArrowMark Partners is a private equity based in United States. 19 investments on record, 2 in the last 12 months, latest Oct 2026. Source: https://millionrounds.com/fund/arrowmark-partners (Millionrounds; every figure on the page links to its filing or article) United States · [Investor](https://millionrounds.com/investors) # ArrowMark Partners Last cheque observed Oct 2026; 19 cheques on record. Email Deploying now New fund $1.1B, May 2023 Private equity Seed Series A Series B Credit Real Estate Equity Follow ArrowMark Partners and see its new cheques in your feed. [Start following](https://millionrounds.com/login?join=1&why=follow&next=%2Ffund%2Farrowmark-partners) Deploying now **100%** of best year **2** **cheques in 12 months**, 19 on record Since the last cheque **2** days **00** hrs **00** min **00** sec Median round **$93M** Rounds led **1 of 19** Mostly in **United States, 89%** Pitch ArrowMark Partners ## ArrowMark Partners highlights - 01 2 cheques in the last 12 months - 02 Mostly Series C and Series B: 80% of its rounds - 03 Led 1 rounds ## What they do > ArrowMark Partners is a privately held, employee-owned investment management firm... We manage assets on behalf of a broad array of institutional clients and private wealth allocators across our investment strategies. From their own website - **Type:** Private equity (from a list, unverified) - **Cheque size:** Not stated - **Stages:** Seed Series A Series B Growth Pre-IPO - **Sectors:** Credit Real Estate Equity - **Based in:** Denver, United States - **Cold pitches:** Not accepted ## The record Every round we can evidence, newest first **19 appearances** - **2026** 2 rounds - **Oct** **[Dren Bio](https://millionrounds.com/company/dren-bio)** US · Wowtale **$350M** With 13 others - **Feb** **[Skyryse](https://millionrounds.com/company/skyryse)** Series C · US · TechCrunch **$300M** With 14 others - **2024** 1 round - **May** **[Zenas BioPharma](https://millionrounds.com/company/zenas-biopharma)** Series C · US · Tellus BioVentures **$200M** With 14 others - **2019** 3 rounds - **Dec** **[ArcherDx](https://millionrounds.com/company/archerdx)** Series C · US · FinSMEs **$55M** With 8 others - **Aug** **[ORIC Pharmaceuticals](https://millionrounds.com/company/oric-pharmaceuticals)** Series D · US · Pharmanewsdaily **$55M** *Led* - **Apr** **[SpringWorks Therapeutics](https://millionrounds.com/company/springworks-therapeutics)** Series B · US · FinSMEs **$125M** With 12 others - **2018** 10 rounds - **Nov** **[NextCure](https://millionrounds.com/company/nextcure)** Series B · MD · Pehub **$93M** With 12 others - **Sept** **[Lyra Therapeutics](https://millionrounds.com/company/lyra-therapeutics)** Series B · US · FinSMEs **$30M** With 5 others - **Aug** **[Evolve Vacation](https://millionrounds.com/company/evolve-vacation)** US · FinSMEs **$80M** With 5 others - **Aug** **[Orchard Therapeutics](https://millionrounds.com/company/orchard-therapeutics)** Series C · GB · FinSMEs **$150M** With 14 others - **Jul** **[Ascentage](https://millionrounds.com/company/ascentage)** Series C · US · FinSMEs **$150M** With 5 others - **Jul** **[Convene](https://millionrounds.com/company/convene)** Series D · US · FinSMEs **$152M** With 8 others - **Jun** **[Metacrine](https://millionrounds.com/company/metacrine)** Series C · US · Globenewswire **$65M** With 5 others - **Apr** **[Kodiak](https://millionrounds.com/company/kodiak)** US · FinSMEs **$33M** With 1 other - **Mar** **[TCR2](https://millionrounds.com/company/tcr2)** Series B · US · FinSMEs **$125M** With 9 others - **Feb** **[Moderna](https://millionrounds.com/company/moderna)** US · FinSMEs **$500M** With 8 others - **2017** 3 rounds - **Dec** **[Neon Therapeutics](https://millionrounds.com/company/neon-therapeutics)** Series B · US · FinSMEs **$36M** With 8 others - **May** **[Convene](https://millionrounds.com/company/convene)** Series C · US · FinSMEs **$68M** With 4 others - **Jan** **[Centrexion](https://millionrounds.com/company/centrexion)** Series D · US · FinSMEs **$67M** With 5 others An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor. ## The team Named by the firm itself, on a filing, its Form ADV or its company registration **2 named** RA **Richard Allen Grove** Chief Compliance Officer i Form ADV SS **Sanjai Suryaji Bhonsle** CEO i Form ADV We also hold **3** people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them. ## What the register says From the firm's own filings with the SEC, which it must file accurately by law **$224M** assets it manages Oct 2026 **Registered** investment adviser full reporting to the SEC - **Legal name:** Arrowmark Asset Management, LLC - **SEC number:** CRD 307161 New fund on file **$1.1B** raised in May 2023 From its SEC filing, not a journalist: a firm that has just raised has money to deploy. ## The cheque Seed Series A Series B Median round joined **$93M** the round, not its cheque Led 1 of 19 rounds **5%** - **Sole investor:** Never alone - **Last cheque:** Oct 2026 Rounds by stage said on their site - Series C *7* - Series B said *5* - Series D *3* - Seed said *-* - Series A said *-* - Growth said *-* - Pre-IPO said *-* Cheques by month Led Joined Nov 2023 Oct 2026 Often in the room with - [Alexandria Real Estate Equities](https://millionrounds.com/fund/alexandria) 3 - [Fidelity](https://millionrounds.com/fund/fidelity) 3 - [Hill House Capital](https://millionrounds.com/fund/hill-house-capital) 3 - [OrbiMed](https://millionrounds.com/fund/orbimed) 3 - [6 Dimensions Capital](https://millionrounds.com/fund/6-dimensions-capital) 2 - [BVF Partners](https://millionrounds.com/fund/bvf-partners) 2 **Pitching ArrowMark Partners?** Put them on your fundraising board with this record on the card, and follow them to hear when they write a new cheque. Add to your CRM *→* ## Who they invest alongside The investors most often in the same rounds as ArrowMark Partners. A count of rooms they were both in, not a relationship either has claimed. [**Alexandria Real Estate Equities** VC firm **3** rounds together](https://millionrounds.com/fund/alexandria)[**Fidelity** VC firm **3** rounds together](https://millionrounds.com/fund/fidelity)[**Hill House Capital** Family office **3** rounds together](https://millionrounds.com/fund/hill-house-capital)[**OrbiMed** Private equity **3** rounds together](https://millionrounds.com/fund/orbimed)[**6 Dimensions Capital** VC firm **2** rounds together](https://millionrounds.com/fund/6-dimensions-capital)[**BVF Partners** VC firm **2** rounds together](https://millionrounds.com/fund/bvf-partners)[**Brookfield** Private equity **2** rounds together](https://millionrounds.com/fund/brookfield)[**Casdin Capital** VC firm **2** rounds together](https://millionrounds.com/fund/casdin-capital)[**Elysium** Growth equity **2** rounds together](https://millionrounds.com/fund/elysium)[**Invus** Private equity **2** rounds together](https://millionrounds.com/fund/invus)[**Lilly Asia Ventures** VC firm **2** rounds together](https://millionrounds.com/fund/lilly-asia-ventures)[**Perceptive Advisors** Asset manager **2** rounds together](https://millionrounds.com/fund/perceptive-advisors) ## Recently backed The latest companies ArrowMark Partners put money into. [**Dren Bio** $350M · Oct 2026](https://millionrounds.com/company/dren-bio)[**Skyryse** $300M · Feb 2026](https://millionrounds.com/company/skyryse)[**Zenas BioPharma** $200M · May 2024](https://millionrounds.com/company/zenas-biopharma)[**ArcherDx** $55M · Dec 2019](https://millionrounds.com/company/archerdx)[**ORIC Pharmaceuticals** $55M · Aug 2019](https://millionrounds.com/company/oric-pharmaceuticals)[**SpringWorks Therapeutics** $125M · Apr 2019](https://millionrounds.com/company/springworks-therapeutics) ## Quick answers about ArrowMark Partners ### What does ArrowMark Partners invest in? ArrowMark Partners invests most often at Series C and Series B (80% of the rounds on record), in sectors such as Credit, Real Estate and Equity. ### How active is ArrowMark Partners? 19 investments on record, 2 of them in the last 12 months, and it led 1. The most recent was in Oct 2026. ### What has ArrowMark Partners invested in recently? Its most recent investments on record: Dren Bio (Undisclosed round, Oct 2026), Skyryse (Series C, Feb 2026) and Zenas BioPharma (Series C, May 2024). ### How big are ArrowMark Partners's cheques? The median round it joins is $93M. ### Does ArrowMark Partners lead rounds? Sometimes: it led 1 of its 19 investments on record (5%). ### Where does ArrowMark Partners invest? Most of the companies it backs are in the United States (89%), Moldova (5%) and the United Kingdom (5%). ### Is ArrowMark Partners investing now? Yes: it is actively investing, with 2 investments in the last 12 months. ### Who does ArrowMark Partners invest alongside? Most often Alexandria Real Estate Equities (3 rounds together), Fidelity (3 rounds together) and Hill House Capital (3 rounds together). ## Raising now? Find the investors who back rounds like yours, and keep every conversation on one fundraising board. Find similar investorsOpen your CRM Built from the rounds we watched, its filings and its own website, refreshed every night. [How we count](https://millionrounds.com/methodology) · [Report a correction](https://millionrounds.com/corrections?slug=arrowmark-partners) · [Is this your firm? Claim it](https://millionrounds.com/claim?org=arrowmark-partners)